Literature DB >> 15308748

Human immunodeficiency virus type 1 matrix inhibits and confers cooperativity on gag precursor-membrane interactions.

David Perez-Caballero1, Theodora Hatziioannou, Juan Martin-Serrano, Paul D Bieniasz.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) Gag multimerization and membrane binding are required for particle formation. However, it is unclear what constitutes a minimal plasma membrane-specific targeting signal and what role the matrix (MA) globular head and other Gag domains play in membrane targeting. Here, we use membrane flotation and microscopic analysis of Gag deletion mutants to demonstrate that the HIV-1 MA globular head inhibits a plasma membrane-specific targeting signal contained within the six amino-terminal MA residues. MA-mediated inhibition is relieved by concentration-dependent Gag multimerization and imparts a high degree of cooperativity on Gag-membrane association. This cooperativity may confer temporal and spatial regulation on HIV-1 assembly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308748      PMCID: PMC506924          DOI: 10.1128/JVI.78.17.9560-9563.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.

Authors:  A Ono; E O Freed
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity.

Authors:  R E Kiernan; A Ono; E O Freed
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

3.  Efficient HIV-1 replication can occur in the absence of the viral matrix protein.

Authors:  H Reil; A A Bukovsky; H R Gelderblom; H G Göttlinger
Journal:  EMBO J       Date:  1998-05-01       Impact factor: 11.598

4.  Differential membrane binding of the human immunodeficiency virus type 1 matrix protein.

Authors:  W Zhou; M D Resh
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.

Authors:  J C Paillart; H G Göttlinger
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

6.  Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism.

Authors:  P Spearman; R Horton; L Ratner; I Kuli-Zade
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

7.  Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly.

Authors:  P Spearman; J J Wang; N Vander Heyden; L Ratner
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

8.  Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids.

Authors:  W Zhou; L J Parent; J W Wills; M D Resh
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

9.  Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal.

Authors:  P P Lee; M L Linial
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

10.  The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag.

Authors:  S Sandefur; V Varthakavi; P Spearman
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

View more
  64 in total

1.  Analysis of human immunodeficiency virus matrix domain replacements.

Authors:  Isabel Scholz; Amelia Still; Tenzin Choesang Dhenub; Kelsey Coday; Mike Webb; Eric Barklis
Journal:  Virology       Date:  2007-11-08       Impact factor: 3.616

2.  Endosomal trafficking of HIV-1 gag and genomic RNAs regulates viral egress.

Authors:  Dorothée Molle; Carolina Segura-Morales; Gregory Camus; Clarisse Berlioz-Torrent; Jorgen Kjems; Eugenia Basyuk; Edouard Bertrand
Journal:  J Biol Chem       Date:  2009-05-18       Impact factor: 5.157

3.  Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin.

Authors:  Nolwenn Jouvenet; Stuart J D Neil; Maria Zhadina; Trinity Zang; Zerina Kratovac; Youngnam Lee; Matthew McNatt; Theodora Hatziioannou; Paul D Bieniasz
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

4.  Quantitative fluorescence resonance energy transfer microscopy analysis of the human immunodeficiency virus type 1 Gag-Gag interaction: relative contributions of the CA and NC domains and membrane binding.

Authors:  Ian B Hogue; Adam Hoppe; Akira Ono
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

5.  Effect of multimerization on membrane association of Rous sarcoma virus and HIV-1 matrix domain proteins.

Authors:  Robert A Dick; Elena Kamynina; Volker M Vogt
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

6.  Rous sarcoma virus gag has no specific requirement for phosphatidylinositol-(4,5)-bisphosphate for plasma membrane association in vivo or for liposome interaction in vitro.

Authors:  Jany Chan; Robert A Dick; Volker M Vogt
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

7.  Isolation and characterization of mouse-human microcell hybrid cell clones permissive for infectious HIV particle release.

Authors:  Ayse K Coskun; Marc van Maanen; David Janka; David Stockton; Pawel Stankiewicz; Pawel Stankiewicsz; Svetlana Yatsenko; Richard E Sutton
Journal:  Virology       Date:  2007-01-31       Impact factor: 3.616

8.  Imaging the biogenesis of individual HIV-1 virions in live cells.

Authors:  Nolwenn Jouvenet; Paul D Bieniasz; Sanford M Simon
Journal:  Nature       Date:  2008-05-25       Impact factor: 49.962

9.  GGA and Arf proteins modulate retrovirus assembly and release.

Authors:  Anjali Joshi; Himanshu Garg; Kunio Nagashima; Juan S Bonifacino; Eric O Freed
Journal:  Mol Cell       Date:  2008-04-25       Impact factor: 17.970

10.  Imaging the interaction of HIV-1 genomes and Gag during assembly of individual viral particles.

Authors:  Nolwenn Jouvenet; Sanford M Simon; Paul D Bieniasz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.